CGA PS-44 (R2022)

CGA PS-44 (R2022)

$20.00

CGA Position Statement on Designated Medical Gases are Not Active Pharmaceutical Ingredients

Published by Publication Date Number of Pages
CGA 02/29/2016 2
PDF FormatPDF FormatMulti-User-AccessMulti-User AccessPrintablePrintableOnline downloadOnline Download
Category:

Description

CGA PS-44 (R2022) – CGA Position Statement on Designated Medical Gases are Not Active Pharmaceutical Ingredients

This position statement answers the question: Are designated medical gases ever considered active pharmaceutical ingredients (API) by the U.S. Food and Drug Administration (FDA).

Product Details

Edition:
1st
Published:
02/29/2016
Number of Pages:
2
File Size:
1 file , 130 KB
Note:
This product is unavailable in Russia, Ukraine, Belarus

In Demand Now